Should the Presence of Lymphvascular Space Involvement Be Used to Assign Patients to Adjuvant Therapy Following Hysterectomy for Unstaged Endometrial Cancer?
- 1 December 2002
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 87 (3) , 243-246
- https://doi.org/10.1006/gyno.2002.6825
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Low-risk corpus cancer: Is lymphadenectomy or radiotherapy necessary?American Journal of Obstetrics and Gynecology, 2000
- Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trialThe Lancet, 2000
- The Use of Adjuvant Radiation Therapy by Members of the Society of Gynecologic OncologistsGynecologic Oncology, 1999
- Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: Report of a prospective trialInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Surgical staging and high dose rate brachytherapy for endometrial cancer: Limiting external radiotherapy to node-positive tumorsObstetrics & Gynecology, 1996
- Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group studyGynecologic Oncology, 1991
- Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group studyCancer, 1987
- The prognostic significance of lymph-vascular space invasion in stage I endometrial cancerCancer, 1985